New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - ferric carboxymaltose 180mg equivalent to iron 50mg - solution for injection - 50 mg/ml - active: ferric carboxymaltose 180mg equivalent to iron 50mg excipient: hydrochloric acid sodium hydroxide water for injection - indicated for the treatment of iron deficiency when oral iron preparations are ineffective, oral preparations cannot be used or there is a clinical need to deliver iron rapidly.

Philippines - English - FDA (Food And Drug Administration)

vifor (international) inc.; importer: zuellig pharma corporation.; distributor: zuellig pharma corporation. - iron (as ferric carboxymaltose) - solution for injection (i.v.) - 50 mg /ml

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vifor (international) inc. - hierro (como carboximaltosa fÉrrica) - hierro (como carboximaltosa fÉrrica)....500.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vifor (international) inc. - hierro iii (como complejo de hidrÓxido de hierro (iii) polimaltosado) - hierro iii (como complejo de hidrÓxido de hierro (iii) polimaltosado)....20 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vifor (international) inc. - hierro sacarato - hierro sacarato....100mg/5ml

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vifor (international) inc. - hierro (iii) como complejo sacarosa hidrÓxido de hierro (iii) - hierro (iii) como complejo sacarosa hidrÓxido de hierro (iii)....100 mg.

European Union - English - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - immunosuppressants - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - iron sucrose 540 mg/ml equivalent to iron 20 mg/ml - solution for injection - 20 mg/ml - active: iron sucrose 540 mg/ml equivalent to iron 20 mg/ml excipient: water for injection - venofer is indicated for the treatment of iron deficiency in the following indications: · where there is a clinical need for a rapid iron supply, · in patients who cannot tolerate oral iron therapy or who are non-compliant, · in active inflammatory bowel disease where oral iron preparations are ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

vifor pharma pty ltd - ulipristal acetate -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - iron polymaltose 50 mg/ml (159mg/ml iron hydroxide polymaltose complex =50mg/ml iron) - solution for injection - 100mg/2ml - active: iron polymaltose 50 mg/ml (159mg/ml iron hydroxide polymaltose complex =50mg/ml iron) excipient: hydrochloric acid sodium hydroxide water for injection - for the prevention and treatment of iron deficiency anaemia in the following circumstances: · when oral therapy is contraindicated · when enteric absorption of iron is defective · when patient non-compliance or persistent gastrointestinal intolerance makes oral therapy impractical · treating iron deficiency anaemia of prematurity and that occurring in geriatric patients · treating iron deficiency states discovered in the third trimester of pregnancy · anaemia resulting from excessive blood loss · where contact between the doctor and patient occurs at irregular intervals